GRN:NYE-iPath® Series B Carbon ETN (USD)

ETF | Commodities Energy |

Last Closing

USD 25.98

Change

-0.37 (-1.39)%

Market Cap

N/A

Volume

163.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Commodities Energy

Symbol Name Price(Change) Market Cap
UGA United States Gasoline Fund LP

+0.09 (+0.15%)

USD 0.10B
UGA United States Gasoline Fund LP

+0.09 (+0.15%)

USD 0.10B
UNL United States 12 Month Natural..

+0.01 (+0.13%)

N/A
DBE Invesco DB Energy Fund

N/A

N/A
USL United States 12 Month Oil Fun..

-0.05 (-0.14%)

N/A
UNG United States Natural Gas Fund..

-0.04 (-0.24%)

N/A
DBO Invesco DB Oil Fund

-0.02 (-0.14%)

N/A
BNO United States Brent Oil Fund L..

-0.05 (-0.18%)

N/A
BNO United States Brent Oil Fund L..

-0.05 (-0.18%)

N/A
DBE Invesco DB Energy Fund

N/A

N/A

ETFs Containing GRN

N/A

Market Performance

  Market Performance vs. Industry/Classification (Commodities Energy) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -15.32% 17% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -15.32% 17% F 11% F
Trailing 12 Months  
Capital Gain -19.04% 50% F 9% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return -19.04% 28% F 9% A-
Trailing 5 Years  
Capital Gain 162.56% 83% B 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 162.56% 83% B 89% A-
Average Annual (5 Year Horizon)  
Capital Gain 40.43% N/A N/A 93% A
Dividend Return 40.43% N/A N/A 91% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 60.60% N/A N/A 14% F
Risk Adjusted Return 66.71% N/A N/A 81% B-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike